Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/altered-promoter-usage-characterizes-monoallelic-transcription-arising-8Lj0YC0N3u
References (57)
-
(1002)
Genes, Chromosomes & Cancer DOI -
R. Neve, B. Ylstra, Chuan-Hsiung Chang, D. Albertson, C. Benz (2002)
ErbB2 Activation of ESX gene expressionOncogene, 21
-
Jane Lo, Sorcheng Lee, Min Xu
Embryogenesis Microarray for Profiling Gene Expression Patterns during 15,000 Unique Zebrafish Est Clusters and Their Future Use in Material Supplemental -
G. Scott, C. Marden, Fan Xu, L. Kirk, C. Benz (2002)
Transcriptional repression of ErbB2 by histone deacetylase inhibitors detected by a genomically integrated ErbB2 promoter-reporting cell screen.Molecular cancer therapeutics, 1 6
-
M. Nezu, H. Sasaki, Y. Kuwahara, T. Ochiya, Y. Yamada, H. Sakamoto, H. Tashiro, M. Yamazaki, T. Ikeuchi, Y. Saito, M. Terada (1999)
Identification of a novel promoter and exons of the c-ERBB-2 gene.Biochemical and biophysical research communications, 258 3
-
A. Hellman, Eitan Zlotorynski, S. Scherer, J. Cheung, J. Vincent, David Smith, L. Trakhtenbrot, B. Kerem (2002)
A role for common fragile site induction in amplification of human oncogenes.Cancer cell, 1 1
-
A. Gimelbrant, A. Ensminger, Peimin Qi, J. Zucker, A. Chess (2005)
Monoallelic Expression and Asynchronous Replication of p120 Catenin in Mouse and Human Cells*Journal of Biological Chemistry, 280
-
M. Tal, C. King, M. Kraus, A. Ullrich, J. Schlessinger, D. Givol (1987)
Human HER2 (neu) promoter: evidence for multiple mechanisms for transcriptional initiationMolecular and Cellular Biology, 7
-
H. Lo, Zhining Wang, Ying Hu, Howard Yang, Sheryl Gere, K. Buetow, M. Lee (2003)
Allelic variation in gene expression is common in the human genome.Genome research, 13 8
-
R. Ohlsson, B. Tycko, C. Sapienza (1998)
Monoallelic expression: 'there can only be one'.Trends in genetics : TIG, 14 11
-
G. Mizuguchi, C. Kanei-Ishii, T. Sawazaki, M. Horikoshi, R. Roeder, Tadashi Yamamoto, Shunsuke Ishii (1994)
Independent control of transcription initiations from two sites by an initiator‐like element and TATA box in the human c‐erb B‐2 promoterFEBS Letters, 348
-
A. Gimelbrant, A. Chess (2006)
An epigenetic state associated with areas of gene duplication.Genome research, 16 6
-
E. Andrechek, W. Hardy, P. Siegel, Michael Rudnicki, R. Cardiff, W. Muller (2000)
Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis.Proceedings of the National Academy of Sciences of the United States of America, 97 7
-
G. Scott, Chuan-Hsiung Chang, K. Erny, Fan Xu, W. Fredericks, F. Rauscher, A. Thor, C. Benz (2000)
Ets regulation of the erbB2 promoterOncogene, 19
-
J. Doherty, C. Bond, A. Jardim, J. Adelman, G. Clinton (1999)
The HER-2/neu receptor tyrosine kinase gene encodes a secreted autoinhibitor.Proceedings of the National Academy of Sciences of the United States of America, 96 19
-
N. Puget, Melodie Knowlton, R. Scully (2005)
Molecular analysis of sister chromatid recombination in mammalian cells.DNA repair, 4 2
-
Shirley Smith, Naomi Bowers, Daniel Betticher, Oliver Gautschi, D. Ratschiller, Paul Hoban, R. Booton, Mauro Santibanez-Koref, J. Heighway (2005)
Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instabilityBritish Journal of Cancer, 93
-
H. Burstein (2005)
The distinctive nature of HER2-positive breast cancers.The New England journal of medicine, 353 16
-
A. Raziuddin, D. Court, F. Sarkar, Ya-lun Liu, H. Kung, R. Raziuddin (1997)
A c-erbB-2 Promoter-specific Nuclear Matrix Protein from Human Breast Tumor Tissues Mediates NF-κB DNA Binding Activity*The Journal of Biological Chemistry, 272
-
Guliang Wang, K. Vasquez (2004)
Naturally occurring H-DNA-forming sequences are mutagenic in mammalian cells.Proceedings of the National Academy of Sciences of the United States of America, 101 37
-
E. Liu, A. Thor, M. He, M. Barcos, B. Ljung, C. Benz (1992)
The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast.Oncogene, 7 5
-
Tony Godfrey, Sun-Hun Kim, Marielena Chavira, David Ruff, Robert Warren, J. Gray, Ronald Jensen (2000)
Quantitative mRNA expression analysis from formalin-fixed, paraffin-embedded tissues using 5' nuclease quantitative reverse transcription-polymerase chain reaction.The Journal of molecular diagnostics : JMD, 2 2
-
K. Livak, Thomas Schmittgen (2001)
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.Methods, 25 4
-
E. Andrechek, Michael Laing, A. Girgis-Gabardo, P. Siegel, R. Cardiff, W. Muller (2003)
Gene expression profiling of neu-induced mammary tumors from transgenic mice reveals genetic and morphological similarities to ErbB2-expressing human breast cancers.Cancer research, 63 16
-
G. Hamilton, N. Brown, V. Oseroff, B. Huey, R. Segraves, D. Sudar, J. Kumler, D. Albertson, D. Pinkel (2006)
A large field CCD system for quantitative imaging of microarraysNucleic Acids Research, 34
-
L. Coussens, Teresa Yang−Feng, Y. Liao, E. Chen, A. Gray, J. Mcgrath, P. Seeburg, T. Libermann, J. Schlessinger, U. Francke, A. Levinson, A. Ullrich (1985)
Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene.Science, 230 4730
-
Amanda Ewart-Toland, P. Briassouli, J. Koning, J. Mao, Jinwei Yuan, F. Chan, L. MacCarthy-Morrogh, B. Ponder, H. Nagase, J. Burn, S. Ball, Maria Almeida, S. Linardopoulos, A. Balmain (2003)
Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and humanNature Genetics, 34
-
P. Buckland (2004)
Allele-specific gene expression differences in humans.Human molecular genetics, 13 Spec No 2
-
Y. Hosokawa, A. Arnold (1998)
Mechanism of cyclin D1 (CCND1, PRAD1) overexpression in human cancer cells: Analysis of allele‐specific expressionGenes, 22
-
P. Benusiglio, F. Lesueur, C. Luccarini, Don Conroy, M. Shah, D. Easton, N. Day, A. Dunning, P. Pharoah, B. Ponder (2005)
Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case–control studyBreast Cancer Research, 7
-
A. Snijders, N. Nowak, R. Segraves, S. Blackwood, Nils Brown, J. Conroy, G. Hamilton, A. Hindle, B. Huey, Karen Kimura, Sindy Law, K. Myambo, J. Palmer, B. Ylstra, J. Yue, J. Gray, Ajay Jain, D. Pinkel, D. Albertson (2001)
Assembly of microarrays for genome-wide measurement of DNA copy numberNature Genetics, 29
-
D. Pinkel, R. Segraves, D. Sudar, S. Clark, I. Poole, D. Kowbel, C. Collins, W. Kuo, Chira Chen, Y. Zhai, S. Dairkee, B. Ljung, J. Gray, D. Albertson (1998)
High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarraysNature Genetics, 20
-
S. Ishii, F. Imamoto, Y. Yamanashi, K. Toyoshima, T. Yamamoto (1987)
Characterization of the promoter region of the human c-erbB-2 protooncogene.Proceedings of the National Academy of Sciences of the United States of America, 84 13
-
A. Chess (1998)
Expansion of the Allelic Exclusion Principle?Science, 279
-
P. Borst, P. Genest (2006)
Parasitology: Switching like for likeNature, 439
-
M. Nezu, Michiko Nishigaki, T. Ishizuka, Y. Kuwahara, C. Tanabe, K. Aoyagi, H. Sakamoto, Y. Saito, T. Yoshida, H. Sasaki, M. Terada (2002)
Identification of the CAB2/hCOS16 Gene Required for the Repair of DNA Double‐strand Breaks on a Core Amplified Region of the 17ql2 Locus in Breast and Gastric CancersJapanese Journal of Cancer Research : Gann, 93
-
Hai Yan, Z. Dobbie, S. Gruber, S. Markowitz, Kathy Romans, F. Giardiello, K. Kinzler, B. Vogelstein (2002)
Small changes in expression affect predisposition to tumorigenesisNature Genetics, 30
-
L. Savelyeva, M. Schwab (2001)
Amplification of oncogenes revisited: from expression profiling to clinical application.Cancer letters, 167 2
-
K. Gary, Scott, Robert Robles, W. 'JOHN, Park, Pamela Montgomery, '. Daniel, William Holmes, James Lee, Gilbert Keller, WEN-LU Li, B. Fendly, William Wood, H. Shepard, C. Christopher, Benz (1993)
A truncated intracellular HER2/neu receptor produced by alternative RNA processing affects growth of human carcinoma cellsMolecular and Cellular Biology, 13
-
A. Snijders, J. Fridlyand, D. Mans, R. Segraves, Ajay Jain, D. Pinkel, D. Albertson (2003)
Shaping of tumor and drug-resistant genomes by instability and selectionOncogene, 22
-
S. Oshii (1987)
Characterization of the promoter region of the human c-erb B-2 proto-oncogene, 84
-
(1992)
The HER 2 ( c - erbB2 ) -
B. Shykind (2005)
Regulation of odorant receptors: one allele at a time.Human molecular genetics, 14 Spec No 1
-
Y. Kuwahara, C. Tanabe, T. Ikeuchi, K. Aoyagi, Michiko Nishigaki, H. Sakamoto, K. Hoshinaga, Teruhiko Yoshida, H. Sasaki, M. Terada (2004)
Alternative mechanisms of gene amplification in human cancersGenes, 41
-
Elena Allen, S. Horvath, F. Tong, P. Kraft, E. Spiteri, A. Riggs, Y. Marahrens (2003)
High concentrations of long interspersed nuclear element sequence distinguish monoallelically expressed genesProceedings of the National Academy of Sciences of the United States of America, 100
-
J. Fridlyand, A. Snijders, B. Ylstra, Hua Li, A. Olshen, R. Segraves, S. Dairkee, T. Tokuyasu, B. Ljung, Ajay Jain, Jane McLennan, J. Ziegler, K. Chin, S. Devries, H. Feiler, J. Gray, F. Waldman, D. Pinkel, D. Albertson (2006)
Breast tumor copy number aberration phenotypes and genomic instabilityBMC Cancer, 6
-
E. Schuur, R. Weigel (2000)
Monoallelic Amplification of Estrogen Receptor-α Expression in Breast CancerCancer Research, 60
-
Ajay Jain, T. Tokuyasu, A. Snijders, R. Segraves, D. Albertson, D. Pinkel (2002)
Fully automatic quantification of microarray image data.Genome research, 12 2
-
Hai Yan, W. Zhou (2004)
Allelic variations in gene expressionCurrent Opinion in Oncology, 16
-
M. Kraus, N. Popescu, S. Amsbaugh, C. King (1987)
Overexpression of the EGF receptor‐related proto‐oncogene erbB‐2 in human mammary tumor cell lines by different molecular mechanisms.The EMBO Journal, 6
-
K. Rhoades, Nandita Singh, I. Simon, B. Glidden, H. Cedar, A. Chess (2000)
Allele-specific expression patterns of interleukin-2 and Pax-5 revealed by a sensitive single-cell RT-PCR analysisCurrent Biology, 10
-
Z. Dotan, A. Dotan, T. Litmanovitch, Y. Ravia, N. Oniashvili, I. Leibovitch, J. Ramon, L. Avivi (2000)
Modification in the inherent mode of allelic replication in lymphocytes of patients suffering from renal cell carcinoma: A novel genetic alteration associated with malignancyGenes, 27
-
Farida Jhabvala-Romero, A. Evans, Shuhua Guo, Michael Denton, G. Clinton (2003)
Herstatin inhibits heregulin-mediated breast cancer cell growth and overcomes tamoxifen resistance in breast cancer cells that overexpress HER-2Oncogene, 22
-
D. Ginzinger (2002)
Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream.Experimental hematology, 30 6
-
G. Scott, J. Daniel, X. Xiong, R. Maki, D. Kabat, C. Benz (1994)
Binding of an ETS-related protein within the DNase I hypersensitive site of the HER2/neu promoter in human breast cancer cells.The Journal of biological chemistry, 269 31
-
C. Marx, C. Berger, Fan Xu, Cliff Amend, G. Scott, B. Hann, John Park, C. Benz (2006)
Validated high-throughput screening of drug-like small molecules for inhibitors of ErbB2 transcription.Assay and drug development technologies, 4 3
-
P. Kauraniemi, A. Kallioniemi (2006)
Activation of multiple cancer-associated genes at the ERBB2 amplicon in breast cancer.Endocrine-related cancer, 13 1
- Publisher
- Wiley
- Copyright
- Copyright © 2006 Wiley‐Liss, Inc., A Wiley Company
- ISSN
- 1045-2257
- eISSN
- 1098-2264
- DOI
- 10.1002/gcc.20364
- pmid
- 16883574
- Publisher site
- See Article on Publisher Site
Abstract
Analysis of a collection of human breast cancers (n = 150), enriched in ERBB2‐positive cases (n = 57) and involving tumor genotyping relative to population‐matched blood genotyping (n = 749) for a common ERBB2 single nucleotide polymorphism Ala(G)1170Pro(C), revealed that ERBB2 amplification in breast cancer is invariably monoallelic. Analysis of paired breast cancer and blood samples from informative (G1170C heterozygotic) ERBB2‐positive (n = 12) and ERBB2‐negative (n = 17) cases not only confirmed monoallelic amplification and ERBB2 transcriptional overexpression but also revealed that most low ERBB2 expressing breast cancers (12/17) exhibit unbalanced allelic transcription, showing 3‐fold to nearly 5,000‐fold preferential expression from one of two inherited alleles. To explore cis‐acting transcriptional mechanisms potentially selected during ERBB2 amplification, levels of four different ERBB2 transcript variants (5.2, 4.7, 2.1, and 1.4 kb) were correlated with total (4.6 kb) ERBB2 mRNA levels in ERBB2‐positive (n = 14) versus ERBB2‐negative (n = 43) primary breast cancers. Relative expression of only the 2.1 kb extracellular domain‐encoding splice variant and a 4.7 kb mRNA variant that uses an alternative start site were significantly increased in association with ERBB2‐positivity, implicating altered promoter usage and selective transcript regulation within the ERBB2 amplicon. Altogether, these findings provide new mechanistic insights into the development of ERBB2‐positive breast cancer and strong rationale for delineating candidate cis‐acting regulatory elements that may link allele‐specific ERBB2 transcription in premalignant breast epithelia with subsequent development of breast cancers bearing monoallelic ERBB2 amplicons. © 2006 Wiley‐Liss, Inc.
Journal
Genes, Chromosomes and Cancer – Wiley
Published: Nov 1, 2006